Methodologies and tools for proton beam design for lung tumors.
about
Particle therapy for non-small cell lung tumors: where do we stand? A systematic review of the literatureProton radiobiologyCan megavoltage computed tomography reduce proton range uncertainties in treatment plans for patients with large metal implants?Radiation techniques in neuro-oncologyIntensity modulated proton therapy treatment planning using single-field optimization: the impact of monitor unit constraints on plan quality.Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lunEvaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer.Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practiceComparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastomaProton therapy in adjuvant treatment of gastric cancer: planning comparison with advanced x-ray therapy and feasibility report.Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer.Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy.Does kV-MV dual-energy computed tomography have an advantage in determining proton stopping power ratios in patients?Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers.Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer.Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancerA beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties.External-beam accelerated partial breast irradiation using multiple proton beam configurations.Risk-optimized proton therapy to minimize radiogenic second cancers.Predictive Risk of Radiation Induced Cerebral Necrosis in Pediatric Brain Cancer Patients after VMAT Versus Proton Therapy.Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment.Fast range-corrected proton dose approximation method using prior dose distribution.Comprehensive analysis of proton range uncertainties related to patient stopping-power-ratio estimation using the stoichiometric calibrationEffects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer.Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer.FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapyThe potential of proton beam radiation therapy in lung cancer (including mesothelioma).Standardized treatment planning methodology for passively scattered proton craniospinal irradiation.Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.Proton therapy radiation pneumonitis local dose-response in esophagus cancer patientsImpact of margin size on the predicted risk of radiogenic second cancers following proton arc therapy and volumetric modulated arc therapy for prostate cancerFour-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer.Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits?Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer.Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer: are proton plans more sensitive to breathing motion?Proton beam therapy and concurrent chemotherapy for esophageal cancer.Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.
P2860
Q27023426-442CB6B2-942D-4968-B3AE-BB30E44F7369Q27025061-DC7AF034-5A41-4704-A8C6-F4A08C734238Q28654979-51B133FB-FCF8-4978-A1DB-CAA2C3638076Q30371425-A96E4E62-7D82-4192-BA07-76154CD5F642Q33724320-0FC69F73-C4F9-41B2-A95C-F246989DD26CQ33843608-B7EDC34A-5E47-42D3-A46D-E5D6D4CE28BDQ33860897-1746671E-22E6-4D6E-A58F-5B7E9290DAADQ33864141-893956BF-A8C8-419A-A0BA-5FFCCFD5531DQ34187098-EF468A74-DA23-4780-B5B0-F8E7E388A780Q34228231-5AE518C6-5A14-4A59-B9FE-30AD96F89F66Q34350198-D9FE51FE-3B44-4A8F-93BD-4C07B8A88261Q34418908-1F30FD06-562D-4DD7-B6AD-644AEAEAA1A0Q35050966-F7EE6686-5D5F-4251-B9E8-782CEAB327F4Q35069288-51D88F47-3F48-48C1-8DE7-519C589A16EFQ35129683-9CA8BFF9-BC3F-43C5-BF4D-50745356E9B8Q35163969-F96C5E22-DE26-48EA-AF9F-2A90A49341DFQ35216097-DCD6287F-03E2-4145-92D3-693471889C63Q35216218-2F3D0DD5-F0C8-40DE-ADF2-7E650BA81109Q35243057-03D7F423-334C-4ABC-96EB-A651CB41C05DQ35644734-5476A70D-7416-458A-9433-9D467325404FQ35646914-0F13ABB5-7BF7-4B91-9D5A-8A36B7A0ADB4Q35818413-249BC35A-0E2A-4A81-AE0C-E8F952A00034Q35933778-BCAA40CB-085B-4BCD-A806-99EBD04AF9B5Q36073300-DD2766B3-F35B-4360-B25F-1A85AC7FF574Q36094562-FFBEA80B-B65C-4A6B-8C1C-4E616EDFA675Q36105956-66614566-41C9-482D-860A-4A5DAE582017Q36133461-7BDC5CEF-5AB8-47A9-B542-6290E77F52F6Q36239986-96792BFC-4BD0-46FB-99AE-4DDDB5EFD0EAQ36333008-D35532A4-FC59-42CA-A070-A861A12D8A85Q36710649-C9D5CB60-C60E-4F38-87E4-4EFC4020A49FQ36805626-DF0D55D7-39E4-45C6-BF59-3EDB1D8C04C1Q36818873-12680AC4-603E-4604-9844-D495BB334FDBQ36968104-AC26A85B-2C91-4AD7-80B0-61716A038A1FQ36983931-39D2F0D8-9C44-476C-BE4A-FAB288A22F28Q37030546-120309F7-D60C-4BD2-A9FC-721684037BB3Q37127147-547F2796-DA35-40C8-B3B0-F6086344C105Q37169653-94831082-900C-40D3-9566-624E56CC89A2Q37301157-60C5FC32-46A5-4688-885A-3B3F0837198CQ37582515-D028D938-348B-401F-B27D-4BB9B19B35D6Q37587783-AC4CA76E-DFBB-4B93-820B-646BDA154D40
P2860
Methodologies and tools for proton beam design for lung tumors.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Methodologies and tools for proton beam design for lung tumors.
@en
Methodologies and tools for proton beam design for lung tumors.
@nl
type
label
Methodologies and tools for proton beam design for lung tumors.
@en
Methodologies and tools for proton beam design for lung tumors.
@nl
prefLabel
Methodologies and tools for proton beam design for lung tumors.
@en
Methodologies and tools for proton beam design for lung tumors.
@nl
P2093
P1476
Methodologies and tools for proton beam design for lung tumors.
@en
P2093
P304
P356
10.1016/S0360-3016(00)01555-8
P407
P577
2001-04-01T00:00:00Z